Australia TGA ARTG recordEndoscopic electrosurgical biopsy/resection cap trial
Australia TGA ARTG Registered Device · Endotherapeutics Pty Ltd · Ovesco Endoscopy AG · Class Is · Started June 19, 2023
Good Name: Endotherapeutics Pty Ltd - Endoscopic electrosurgical biopsy/resection cap trial
- Risk Class
- Class Is
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- June 19, 2023
- Effective Date
- June 19, 2023
- Country
- Germany
- Address
- Friedrich-Miescher-Str. 9, Tubingen, 72076
The FTRD prOVE Cap is intended to be used before the planned application of an FTRD Set. The FTRD proVE Cap is placed on a flexible endoscope in order to test whether the lesion to be resected can be reached by, and pulled into, the FTRD Cap.
Access comprehensive regulatory information for Endoscopic electrosurgical biopsy/resection cap trial in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class Is is sponsored by Endotherapeutics Pty Ltd, manufactured by Ovesco Endoscopy AG in Germany. The device registration started on June 19, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.